Serial Number | 75602028 |
Word Mark | ENBREL |
Filing Date | Wednesday, December 9, 1998 |
Status | 710 - CANCELLED - SECTION 8 |
Status Date | Saturday, August 11, 2007 |
Registration Number | 2402704 |
Registration Date | Tuesday, November 7, 2000 |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, October 19, 1999 |
Goods and Services | Providing health and medical information relating to human immune diseases and conditions |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Saturday, August 11, 2007 |
Primary Code | 042 |
First Use Anywhere Date | Saturday, October 31, 1998 |
First Use In Commerce Date | Saturday, October 31, 1998 |
Party Name | Immunex Corporation |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Seattle, WA 98101 |
Party Name | Immunex Corporation |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Seattle, WA 98101 |
Party Name | Immunex Corporation |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Seattle, WA 98101 |
Event Date | Event Description |
Saturday, August 11, 2007 | CANCELLED SEC. 8 (6-YR) |
Wednesday, August 9, 2006 | CASE FILE IN TICRS |
Tuesday, November 7, 2000 | REGISTERED-PRINCIPAL REGISTER |
Friday, September 15, 2000 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Tuesday, September 12, 2000 | STATEMENT OF USE PROCESSING COMPLETE |
Tuesday, July 11, 2000 | USE AMENDMENT FILED |
Tuesday, January 11, 2000 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, October 19, 1999 | PUBLISHED FOR OPPOSITION |
Friday, September 17, 1999 | NOTICE OF PUBLICATION |
Thursday, June 10, 1999 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, June 4, 1999 | ASSIGNED TO EXAMINER |